市場調査レポート
商品コード
1464022

生体模倣システム - 世界市場のシェアとランキング、全体の売上と需要の予測(2024年~2030年)

Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

出版日: | 発行: QYResearch | ページ情報: 英文 218 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
生体模倣システム - 世界市場のシェアとランキング、全体の売上と需要の予測(2024年~2030年)
出版日: 2024年04月18日
発行: QYResearch
ページ情報: 英文 218 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生体模倣システムの市場規模は、2023年に1億1,301万米ドルと推定され、2030年までに7億2,143万米ドルに達し、2024年~2030年にCAGRで30.27%の成長が見込まれます。

北米の市場規模は、2023年に4,949万米ドルであり、2030年までに2億9,382万米ドルに達する見込みで、予測期間のCAGRは28.80%です。

アジア太平洋の市場規模は、2023年に1,261万米ドルであり、2030年までに8,840万米ドルに達する見込みで、予測期間のCAGRは31.95%です。

欧州の市場規模は、2023年に4,754万米ドルであり、2030年までに3億2,023万米ドルに達する見込みで、予測期間のCAGRは31.44%です。

世界の生体模倣システムの主要企業は、Emulate、Mimetas、InSphero、TissUse、CN Bio、Valo Health(TARA Biosystems)、Hesperos、TNO、AxoSim、Newcells Biotech、Nortis、Netri、Draper Laboratory、Beijing Daxiang Biotech、Altis Biosystems、Cherry Biotech、Bi/ond、Obatala Sciences、Ananda Devices、ImmuONE、React4life、AlveoliX、BiomimX、Aracari Bio、StemPharm、SynVivoなどです。2023年、世界の主要5社が収益で約49.02%のシェアを占めました。

当レポートでは、世界の生体模倣システム市場について調査分析し、各地域の市場規模と予測、主要企業の市場シェア、ランキングなどを提供しています。

目次

第1章 市場の概要

  • 生体模倣システム製品のイントロダクション
  • 世界の生体模倣システムの市場規模の予測(2019年~2030年)
  • 生体模倣システム市場の動向と促進要因
    • 生体模倣システム産業の動向
    • 生体模倣システム市場の促進要因と機会
    • 生体模倣システム市場の課題
    • 生体模倣システム市場の抑制要因
  • 前提条件と制限
  • 調査目的
  • 考慮される年数

第2章 競合分析:企業別

  • 世界の生体模倣システム企業の収益ランキング(2023年)
  • 世界の生体模倣システムの収益:企業別(2019年~2024年)
  • 主要企業の生体模倣システムの本社、販売地域
  • 主要企業の生体模倣システムの提供製品
  • 世界の主要生体模倣システム企業の設立日
  • 生体模倣システム市場の競合分析
    • 生体模倣システムの市場集中度(2019年~2024年)
    • 世界の生体模倣システムの5大・10大企業(収益)(2023年)
    • 世界の主要企業:企業タイプ別(Tier 1・Tier 2・Tier 3)(2023年時点の生体模倣システムの収益に基づく)
  • 合併と買収、拡大

第3章 セグメント:タイプ別

  • イントロダクション:タイプ別
    • ヒト臓器、組織モデル
    • 疾患モデル
    • 非ヒトモデル
  • 世界の生体模倣システムの売上:タイプ別
    • 世界の生体模倣システムの売上:タイプ別(2019年・2023年・2030年)
    • 世界の生体模倣システムの売上:タイプ別(2019年~2030年)
    • 世界の生体模倣システムの売上:タイプ別(2019年~2030年)

第4章 セグメント:エンドユーザー別

  • イントロダクション:エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 学術・研究機関
    • その他
  • 世界の生体模倣システムの売上:エンドユーザー別
    • 世界の生体模倣システムの売上:エンドユーザー別(2019年・2023年・2030年)
    • 世界の生体模倣システムの売上:エンドユーザー別(2019年~2030年)
    • 世界の生体模倣システムの売上:エンドユーザー別(2019年~2030年)

第5章 セグメント:地域別

  • 世界の生体模倣システムの売上:地域別
    • 世界の生体模倣システムの売上:地域別(2019年・2023年・2030年)
    • 世界の生体模倣システムの売上:地域別(2019年~2024年)
    • 世界の生体模倣システムの売上:地域別(2025年~2030年)
    • 世界の生体模倣システムの売上:地域別(2019年~2030年)
  • 北米
    • 北米の生体模倣システムの売上(2019年~2030年)
    • 北米の生体模倣システムの売上:国別(2023年・2030年)
  • 欧州
    • 欧州の生体模倣システムの売上(2019年~2030年)
    • 欧州の生体模倣システムの売上:国別(2023年・2030年)
  • アジア太平洋
    • アジア太平洋の生体模倣システムの売上(2019年~2030年)
    • アジア太平洋の生体模倣システムの売上:地域別(2023年・2030年)
  • ラテンアメリカ
    • ラテンアメリカの生体模倣システムの売上(2019年~2030年)
    • ラテンアメリカの生体模倣システムの売上:国別(2023年・2030年)
  • 中東・アフリカ

第6章 セグメント:主要国/地域別

  • 主要国/地域の生体模倣システムの売上の成長動向(2019年・2023年・2030年)
  • 主要国/地域の生体模倣システムの売上(2019年~2030年)
  • 米国
    • 米国の生体模倣システムの売上(2019年~2030年)
    • 米国の生体模倣システムの売上:タイプ別(2023年・2030年)
    • 米国の生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • 欧州
    • 欧州の生体模倣システムの売上(2019年~2030年)
    • 欧州の生体模倣システムの売上:タイプ別(2023年・2030年)
    • 欧州の生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • 中国
    • 中国の生体模倣システムの売上(2019年~2030年)
    • 中国の生体模倣システムの売上:タイプ別(2023年・2030年)
    • 中国の生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • 日本
    • 日本の生体模倣システムの売上(2019年~2030年)
    • 日本の生体模倣システムの売上:タイプ別(2023年・2030年)
    • 日本の生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • 韓国
    • 韓国の生体模倣システムの売上(2019年~2030年)
    • 韓国の生体模倣システムの売上:タイプ別(2023年・2030年)
    • 韓国の生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • 東南アジア
    • 東南アジアの生体模倣システムの売上(2019年~2030年)
    • 東南アジアの生体模倣システムの売上:タイプ別(2023年・2030年)
    • 東南アジアの生体模倣システムの売上:エンドユーザー別(2023年・2030年)
  • インド
    • インドの生体模倣システムの売上(2019年~2030年)
    • インドの生体模倣システムの売上:タイプ別(2023年・2030年)
    • インドの生体模倣システムの売上:エンドユーザー別(2023年・2030年)

第7章 企業プロファイル

  • Emulate
  • Mimetas
  • InSphero
  • TissUse
  • CN Bio
  • Valo Health (TARA Biosystems)
  • Hesperos
  • TNO
  • AxoSim
  • Newcells Biotech
  • Nortis
  • Netri
  • Draper Laboratory
  • Beijing Daxiang Biotech
  • Altis Biosystems
  • Cherry Biotech
  • Bi/ond
  • Obatala Sciences
  • Ananda Devices
  • ImmuONE
  • React4life
  • AlveoliX
  • BiomimX
  • Aracari Bio
  • StemPharm
  • SynVivo

第8章 産業チェーン分析

  • 生体模倣システムの産業チェーン
  • 生体模倣システムの上流分析
    • 上流分析
    • 原材料の主要サプライヤー
    • 製造コスト構造
  • 下流分析(顧客分析)
  • 販売モデル、販売チャネル

第9章 調査結果と結論

第10章 付録

図表

List of Tables

  • Table 1. Microphysiological System Market Trends
  • Table 2. Microphysiological System Market Drivers & Opportunity
  • Table 3. Microphysiological System Market Challenges
  • Table 4. Microphysiological System Market Restraints
  • Table 5. Global Microphysiological System Revenue by Company (2019-2024) & (US$ Million)
  • Table 6. Global Microphysiological System Revenue Market Share by Company (2019-2024)
  • Table 7. Key Companies Microphysiological System Headquarters and Sales Area
  • Table 8. Key Companies Microphysiological System Product
  • Table 9. Establish Date of Global Key Microphysiological System Companies
  • Table 10. Global Microphysiological System Companies Market Concentration Ratio (CR5)
  • Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Microphysiological System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 14. Global Microphysiological System Sales Value by Type (2019-2024) & (US$ Million)
  • Table 15. Global Microphysiological System Sales Value by Type (2025-2030) & (US$ Million)
  • Table 16. Global Microphysiological System Sales Market Share in Value by Type (2019-2024)
  • Table 17. Global Microphysiological System Sales Market Share in Value by Type (2025-2030)
  • Table 18. Global Microphysiological System Sales Value by End User: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 19. Global Microphysiological System Sales Value by End User (2019-2024) & (US$ Million)
  • Table 20. Global Microphysiological System Sales Value by End User (2025-2030) & (US$ Million)
  • Table 21. Global Microphysiological System Sales Market Share in Value by End User (2019-2024)
  • Table 22. Global Microphysiological System Sales Market Share in Value by End User (2025-2030)
  • Table 23. Global Microphysiological System Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
  • Table 24. Global Microphysiological System Sales Value by Region (2019-2024) & (US$ Million)
  • Table 25. Global Microphysiological System Sales Value by Region (2025-2030) & (US$ Million)
  • Table 26. Global Microphysiological System Sales Value by Region (2019-2024) & (%)
  • Table 27. Global Microphysiological System Sales Value by Region (2025-2030) & (%)
  • Table 28. Key Countries/Regions Microphysiological System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
  • Table 29. Key Countries/Regions Microphysiological System Sales Value, (2019-2024) & (US$ Million)
  • Table 30. Key Countries/Regions Microphysiological System Sales Value, (2025-2030) & (US$ Million)
  • Table 31. Emulate Basic Information List
  • Table 32. Emulate Description and Business Overview
  • Table 33. Emulate Microphysiological System Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Microphysiological System Business of Emulate (2019-2024)
  • Table 35. Mimetas Basic Information List
  • Table 36. Mimetas Description and Business Overview
  • Table 37. Mimetas Microphysiological System Products, Services and Solutions
  • Table 38. Revenue (US$ Million) in Microphysiological System Business of Mimetas (2019-2024)
  • Table 39. Mimetas Recent Developments
  • Table 40. InSphero Basic Information List
  • Table 41. InSphero Description and Business Overview
  • Table 42. InSphero Microphysiological System Products, Services and Solutions
  • Table 43. Revenue (US$ Million) in Microphysiological System Business of InSphero (2019-2024)
  • Table 44. InSphero Recent Developments
  • Table 45. TissUse Basic Information List
  • Table 46. TissUse Description and Business Overview
  • Table 47. TissUse Microphysiological System Products, Services and Solutions
  • Table 48. Revenue (US$ Million) in Microphysiological System Business of TissUse (2019-2024)
  • Table 49. CN Bio Basic Information List
  • Table 50. CN Bio Description and Business Overview
  • Table 51. CN Bio Microphysiological System Products, Services and Solutions
  • Table 52. Revenue (US$ Million) in Microphysiological System Business of CN Bio (2019-2024)
  • Table 53. CN Bio Recent Developments
  • Table 54. Valo Health (TARA Biosystems) Basic Information List
  • Table 55. Valo Health (TARA Biosystems) Description and Business Overview
  • Table 56. Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions
  • Table 57. Revenue (US$ Million) in Microphysiological System Business of Valo Health (TARA Biosystems) (2019-2024)
  • Table 58. Valo Health (TARA Biosystems) Recent Developments
  • Table 59. Hesperos Basic Information List
  • Table 60. Hesperos Description and Business Overview
  • Table 61. Hesperos Microphysiological System Products, Services and Solutions
  • Table 62. Revenue (US$ Million) in Microphysiological System Business of Hesperos (2019-2024)
  • Table 63. TNO Basic Information List
  • Table 64. TNO Description and Business Overview
  • Table 65. TNO Microphysiological System Products, Services and Solutions
  • Table 66. Revenue (US$ Million) in Microphysiological System Business of TNO (2019-2024)
  • Table 67. AxoSim Basic Information List
  • Table 68. AxoSim Description and Business Overview
  • Table 69. AxoSim Microphysiological System Products, Services and Solutions
  • Table 70. Revenue (US$ Million) in Microphysiological System Business of AxoSim (2019-2024)
  • Table 71. AxoSim Recent Developments
  • Table 72. Newcells Biotech Basic Information List
  • Table 73. Newcells Biotech Description and Business Overview
  • Table 74. Newcells Biotech Microphysiological System Products, Services and Solutions
  • Table 75. Revenue (US$ Million) in Microphysiological System Business of Newcells Biotech (2019-2024)
  • Table 76. Newcells Biotech Recent Developments
  • Table 77. Nortis Basic Information List
  • Table 78. Nortis Description and Business Overview
  • Table 79. Nortis Microphysiological System Products, Services and Solutions
  • Table 80. Revenue (US$ Million) in Microphysiological System Business of Nortis (2019-2024)
  • Table 81. Nortis Recent Developments
  • Table 82. Netri Basic Information List
  • Table 83. Netri Description and Business Overview
  • Table 84. Netri Microphysiological System Products, Services and Solutions
  • Table 85. Revenue (US$ Million) in Microphysiological System Business of Netri (2019-2024)
  • Table 86. Netri Recent Developments
  • Table 87. Draper Laboratory Basic Information List
  • Table 88. Draper Laboratory Description and Business Overview
  • Table 89. Draper Laboratory Microphysiological System Products, Services and Solutions
  • Table 90. Revenue (US$ Million) in Microphysiological System Business of Draper Laboratory (2019-2024)
  • Table 91. Beijing Daxiang Biotech Basic Information List
  • Table 92. Beijing Daxiang Biotech Description and Business Overview
  • Table 93. Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Microphysiological System Business of Beijing Daxiang Biotech (2019-2024)
  • Table 95. Altis Biosystems Basic Information List
  • Table 96. Altis Biosystems Description and Business Overview
  • Table 97. Altis Biosystems Microphysiological System Products, Services and Solutions
  • Table 98. Revenue (US$ Million) in Microphysiological System Business of Altis Biosystems (2019-2024)
  • Table 99. Altis Biosystems Recent Developments
  • Table 100. Cherry Biotech Basic Information List
  • Table 101. Cherry Biotech Description and Business Overview
  • Table 102. Cherry Biotech Microphysiological System Products, Services and Solutions
  • Table 103. Revenue (US$ Million) in Microphysiological System Business of Cherry Biotech (2019-2024)
  • Table 104. Bi/ond Basic Information List
  • Table 105. Bi/ond Description and Business Overview
  • Table 106. Bi/ond Microphysiological System Products, Services and Solutions
  • Table 107. Revenue (US$ Million) in Microphysiological System Business of Bi/ond (2019-2024)
  • Table 108. Obatala Sciences Basic Information List
  • Table 109. Obatala Sciences Description and Business Overview
  • Table 110. Obatala Sciences Microphysiological System Products, Services and Solutions
  • Table 111. Revenue (US$ Million) in Microphysiological System Business of Obatala Sciences (2019-2024)
  • Table 112. Ananda Devices Basic Information List
  • Table 113. Ananda Devices Description and Business Overview
  • Table 114. Ananda Devices Microphysiological System Products, Services and Solutions
  • Table 115. Revenue (US$ Million) in Microphysiological System Business of Ananda Devices (2019-2024)
  • Table 116. Ananda Devices Recent Developments
  • Table 117. ImmuONE Basic Information List
  • Table 118. ImmuONE Description and Business Overview
  • Table 119. ImmuONE Microphysiological System Products, Services and Solutions
  • Table 120. Revenue (US$ Million) in Microphysiological System Business of ImmuONE (2019-2024)
  • Table 121. ImmuONE Recent Developments
  • Table 122. React4life Basic Information List
  • Table 123. React4life Description and Business Overview
  • Table 124. React4life Microphysiological System Products, Services and Solutions
  • Table 125. Revenue (US$ Million) in Microphysiological System Business of React4life (2019-2024)
  • Table 126. AlveoliX Basic Information List
  • Table 127. AlveoliX Description and Business Overview
  • Table 128. AlveoliX Microphysiological System Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in Microphysiological System Business of AlveoliX (2019-2024)
  • Table 130. BiomimX Basic Information List
  • Table 131. BiomimX Description and Business Overview
  • Table 132. BiomimX Microphysiological System Products, Services and Solutions
  • Table 133. Revenue (US$ Million) in Microphysiological System Business of BiomimX (2019-2024)
  • Table 134. Aracari Bio Basic Information List
  • Table 135. Aracari Bio Description and Business Overview
  • Table 136. Aracari Bio Microphysiological System Products, Services and Solutions
  • Table 137. Revenue (US$ Million) in Microphysiological System Business of Aracari Bio (2019-2024)
  • Table 138. StemPharm Basic Information List
  • Table 139. StemPharm Description and Business Overview
  • Table 140. StemPharm Microphysiological System Products, Services and Solutions
  • Table 141. Revenue (US$ Million) in Microphysiological System Business of StemPharm (2019-2024)
  • Table 142. SynVivo Basic Information List
  • Table 143. SynVivo Description and Business Overview
  • Table 144. SynVivo Microphysiological System Products, Services and Solutions
  • Table 145. Revenue (US$ Million) in Microphysiological System Business of SynVivo (2019-2024)
  • Table 146. Upstream Analysis
  • Table 147. Raw Materials Key Suppliers Lists
  • Table 148. Downstream Analysis
  • Table 149. Microphysiological System Downstream Customers
  • Table 150. Microphysiological System Channels Analysis
  • Table 151. Microphysiological System Distributors List
  • Table 152. Research Programs/Design for This Report
  • Table 153. Key Data Information from Secondary Sources
  • Table 154. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Microphysiological System Product Picture
  • Figure 2. Global Microphysiological System Sales Value, 2019 VS 2024 VS 2030 (US$ Million)
  • Figure 3. Global Microphysiological System Sales Value (2019-2030) & (US$ Million)
  • Figure 4. Microphysiological System Report Years Considered
  • Figure 5. Global Microphysiological System Players Revenue Ranking (2023) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Microphysiological System Revenue in 2023
  • Figure 7. Human Organ and Tissue Models Picture
  • Figure 8. Disease Models Picture
  • Figure 9. Non-Human Species Models Picture
  • Figure 10. Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 11. Global Microphysiological System Sales Value Market Share by Type, 2023 & 2030
  • Figure 12. Product Picture of Pharmaceutical & Biotechnology Companies
  • Figure 13. Product Picture of Academic & Research Institutes
  • Figure 14. Product Picture of Others
  • Figure 15. Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 16. Global Microphysiological System Sales Value Market Share by End User, 2023 & 2030
  • Figure 17. North America Microphysiological System Sales Value (2019-2030) & (US$ Million)
  • Figure 18. North America Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • Figure 19. Europe Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 20. Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • Figure 21. Asia Pacific Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 22. Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030
  • Figure 23. Latin America Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 24. Latin America Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • Figure 25. Middle East & Africa Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 26. Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • Figure 27. United States Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 28. United States Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 29. United States Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 30. Europe Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 31. Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 32. Europe Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 33. China Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 34. China Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 35. China Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 36. Japan Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 37. Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 38. Japan Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 39. South Korea Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 40. South Korea Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 41. South Korea Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 42. Southeast Asia Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 43. Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 44. Southeast Asia Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 45. India Microphysiological System Sales Value, (2019-2030) & (US$ Million)
  • Figure 46. India Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • Figure 47. India Microphysiological System Sales Value by End User (%), 2023 VS 2030
  • Figure 48. Microphysiological System Industrial Chain
  • Figure 49. Microphysiological System Manufacturing Cost Structure
  • Figure 50. Bottom-up and Top-down Approaches for This Report
  • Figure 51. Data Triangulation
  • Figure 52. Key Executives Interviewed
目次

The global market for Microphysiological System was estimated to be worth US$ 113.01 million in 2023 and is forecast to a readjusted size of US$ 721.43 million by 2030 with a CAGR of 30.27% during the forecast period 2024-2030.

North American market for Microphysiological System was valued at $ 49.49 million in 2023 and will reach $ 293.82 million by 2030, at a CAGR of 28.80% during the forecast period of 2024 through 2030.

Asia-Pacific market for Microphysiological System was valued at $ 12.61 million in 2023 and will reach $ 88.40 million by 2030, at a CAGR of 31.95% during the forecast period of 2024 through 2030.

Europe market for Microphysiological System was valued at $ 47.54 million in 2023 and will reach $ 320.23 million by 2030, at a CAGR of 31.44% during the forecast period of 2024 through 2030.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, AxoSim, Newcells Biotech, Nortis, Netri, Draper Laboratory, Beijing Daxiang Biotech, Altis Biosystems, Cherry Biotech, Bi/ond, Obatala Sciences, Ananda Devices, ImmuONE, React4life, AlveoliX, BiomimX, Aracari Bio, StemPharm, SynVivo, etc. In 2023, the global five largest players hold a share approximately 49.02% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Microphysiological System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microphysiological System by region & country, by Type, and by End User.

The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.

Market Segmentation

By Company

  • Emulate
  • Mimetas
  • InSphero
  • TissUse
  • CN Bio
  • Valo Health (TARA Biosystems)
  • Hesperos
  • TNO
  • AxoSim
  • Newcells Biotech
  • Nortis
  • Netri
  • Draper Laboratory
  • Beijing Daxiang Biotech
  • Altis Biosystems
  • Cherry Biotech
  • Bi/ond
  • Obatala Sciences
  • Ananda Devices
  • ImmuONE
  • React4life
  • AlveoliX
  • BiomimX
  • Aracari Bio
  • StemPharm
  • SynVivo

Segment by Type

  • Human Organ and Tissue Models
  • Disease Models
  • Non-Human Species Models

Segment by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Microphysiological System Product Introduction
  • 1.2 Global Microphysiological System Market Size Forecast (2019-2030)
  • 1.3 Microphysiological System Market Trends & Drivers
    • 1.3.1 Microphysiological System Industry Trends
    • 1.3.2 Microphysiological System Market Drivers & Opportunity
    • 1.3.3 Microphysiological System Market Challenges
    • 1.3.4 Microphysiological System Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Microphysiological System Players Revenue Ranking (2023)
  • 2.2 Global Microphysiological System Revenue by Company (2019-2024)
  • 2.3 Key Companies Microphysiological System Headquarters and Sales Area
  • 2.4 Key Companies Microphysiological System Product Offered
  • 2.5 Establish Date of Global Key Microphysiological System Companies
  • 2.6 Microphysiological System Market Competitive Analysis
    • 2.6.1 Microphysiological System Market Concentration Rate (2019-2024)
    • 2.6.2 Global 5 and 10 Largest Companies by Microphysiological System Revenue in 2023
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Organ and Tissue Models
    • 3.1.2 Disease Models
    • 3.1.3 Non-Human Species Models
  • 3.2 Global Microphysiological System Sales Value by Type
    • 3.2.1 Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030)
    • 3.2.2 Global Microphysiological System Sales Value, by Type (2019-2030)
    • 3.2.3 Global Microphysiological System Sales Value, by Type (%) (2019-2030)

4 Segmentation by End User

  • 4.1 Introduction by End User
    • 4.1.1 Pharmaceutical & Biotechnology Companies
    • 4.1.2 Academic & Research Institutes
    • 4.1.3 Others
  • 4.2 Global Microphysiological System Sales Value by End User
    • 4.2.1 Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030)
    • 4.2.2 Global Microphysiological System Sales Value, by End User (2019-2030)
    • 4.2.3 Global Microphysiological System Sales Value, by End User (%) (2019-2030)

5 Segmentation by Region

  • 5.1 Global Microphysiological System Sales Value by Region
    • 5.1.1 Global Microphysiological System Sales Value by Region: 2019 VS 2023 VS 2030
    • 5.1.2 Global Microphysiological System Sales Value by Region (2019-2024)
    • 5.1.3 Global Microphysiological System Sales Value by Region (2025-2030)
    • 5.1.4 Global Microphysiological System Sales Value by Region (%), (2019-2030)
  • 5.2 North America
    • 5.2.1 North America Microphysiological System Sales Value, 2019-2030
    • 5.2.2 North America Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • 5.3 Europe
    • 5.3.1 Europe Microphysiological System Sales Value, 2019-2030
    • 5.3.2 Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Microphysiological System Sales Value, 2019-2030
    • 5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030
  • 5.5 Latin America
    • 5.5.1 Latin America Microphysiological System Sales Value, 2019-2030
    • 5.5.2 Latin America Microphysiological System Sales Value by Country (%), 2023 VS 2030
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Microphysiological System Sales Value, 2019-2030
    • 5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2019 VS 2023 VS 2030
  • 6.2 Key Countries/Regions Microphysiological System Sales Value, 2019-2030
  • 6.3 United States
    • 6.3.1 United States Microphysiological System Sales Value, 2019-2030
    • 6.3.2 United States Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.3.3 United States Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.4 Europe
    • 6.4.1 Europe Microphysiological System Sales Value, 2019-2030
    • 6.4.2 Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.4.3 Europe Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.5 China
    • 6.5.1 China Microphysiological System Sales Value, 2019-2030
    • 6.5.2 China Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.5.3 China Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.6 Japan
    • 6.6.1 Japan Microphysiological System Sales Value, 2019-2030
    • 6.6.2 Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.6.3 Japan Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.7 South Korea
    • 6.7.1 South Korea Microphysiological System Sales Value, 2019-2030
    • 6.7.2 South Korea Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.7.3 South Korea Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Microphysiological System Sales Value, 2019-2030
    • 6.8.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.8.3 Southeast Asia Microphysiological System Sales Value by End User, 2023 VS 2030
  • 6.9 India
    • 6.9.1 India Microphysiological System Sales Value, 2019-2030
    • 6.9.2 India Microphysiological System Sales Value by Type (%), 2023 VS 2030
    • 6.9.3 India Microphysiological System Sales Value by End User, 2023 VS 2030

7 Company Profiles

  • 7.1 Emulate
    • 7.1.1 Emulate Profile
    • 7.1.2 Emulate Main Business
    • 7.1.3 Emulate Microphysiological System Products, Services and Solutions
    • 7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.2 Mimetas
    • 7.2.1 Mimetas Profile
    • 7.2.2 Mimetas Main Business
    • 7.2.3 Mimetas Microphysiological System Products, Services and Solutions
    • 7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.2.5 Mimetas Recent Developments
  • 7.3 InSphero
    • 7.3.1 InSphero Profile
    • 7.3.2 InSphero Main Business
    • 7.3.3 InSphero Microphysiological System Products, Services and Solutions
    • 7.3.4 InSphero Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.3.5 InSphero Recent Developments
  • 7.4 TissUse
    • 7.4.1 TissUse Profile
    • 7.4.2 TissUse Main Business
    • 7.4.3 TissUse Microphysiological System Products, Services and Solutions
    • 7.4.4 TissUse Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.5 CN Bio
    • 7.5.1 CN Bio Profile
    • 7.5.2 CN Bio Main Business
    • 7.5.3 CN Bio Microphysiological System Products, Services and Solutions
    • 7.5.4 CN Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.5.5 CN Bio Recent Developments
  • 7.6 Valo Health (TARA Biosystems)
    • 7.6.1 Valo Health (TARA Biosystems) Profile
    • 7.6.2 Valo Health (TARA Biosystems) Main Business
    • 7.6.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions
    • 7.6.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.6.5 Valo Health (TARA Biosystems) Recent Developments
  • 7.7 Hesperos
    • 7.7.1 Hesperos Profile
    • 7.7.2 Hesperos Main Business
    • 7.7.3 Hesperos Microphysiological System Products, Services and Solutions
    • 7.7.4 Hesperos Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.8 TNO
    • 7.8.1 TNO Profile
    • 7.8.2 TNO Main Business
    • 7.8.3 TNO Microphysiological System Products, Services and Solutions
    • 7.8.4 TNO Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.9 AxoSim
    • 7.9.1 AxoSim Profile
    • 7.9.2 AxoSim Main Business
    • 7.9.3 AxoSim Microphysiological System Products, Services and Solutions
    • 7.9.4 AxoSim Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.9.5 AxoSim Recent Developments
  • 7.10 Newcells Biotech
    • 7.10.1 Newcells Biotech Profile
    • 7.10.2 Newcells Biotech Main Business
    • 7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions
    • 7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.10.5 Newcells Biotech Recent Developments
  • 7.11 Nortis
    • 7.11.1 Nortis Profile
    • 7.11.2 Nortis Main Business
    • 7.11.3 Nortis Microphysiological System Products, Services and Solutions
    • 7.11.4 Nortis Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.11.5 Nortis Recent Developments
  • 7.12 Netri
    • 7.12.1 Netri Profile
    • 7.12.2 Netri Main Business
    • 7.12.3 Netri Microphysiological System Products, Services and Solutions
    • 7.12.4 Netri Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.12.5 Netri Recent Developments
  • 7.13 Draper Laboratory
    • 7.13.1 Draper Laboratory Profile
    • 7.13.2 Draper Laboratory Main Business
    • 7.13.3 Draper Laboratory Microphysiological System Products, Services and Solutions
    • 7.13.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.14 Beijing Daxiang Biotech
    • 7.14.1 Beijing Daxiang Biotech Profile
    • 7.14.2 Beijing Daxiang Biotech Main Business
    • 7.14.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions
    • 7.14.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.15 Altis Biosystems
    • 7.15.1 Altis Biosystems Profile
    • 7.15.2 Altis Biosystems Main Business
    • 7.15.3 Altis Biosystems Microphysiological System Products, Services and Solutions
    • 7.15.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.15.5 Altis Biosystems Recent Developments
  • 7.16 Cherry Biotech
    • 7.16.1 Cherry Biotech Profile
    • 7.16.2 Cherry Biotech Main Business
    • 7.16.3 Cherry Biotech Microphysiological System Products, Services and Solutions
    • 7.16.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.17 Bi/ond
    • 7.17.1 Bi/ond Profile
    • 7.17.2 Bi/ond Main Business
    • 7.17.3 Bi/ond Microphysiological System Products, Services and Solutions
    • 7.17.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.18 Obatala Sciences
    • 7.18.1 Obatala Sciences Profile
    • 7.18.2 Obatala Sciences Main Business
    • 7.18.3 Obatala Sciences Microphysiological System Products, Services and Solutions
    • 7.18.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.19 Ananda Devices
    • 7.19.1 Ananda Devices Profile
    • 7.19.2 Ananda Devices Main Business
    • 7.19.3 Ananda Devices Microphysiological System Products, Services and Solutions
    • 7.19.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.19.5 Ananda Devices Recent Developments
  • 7.20 ImmuONE
    • 7.20.1 ImmuONE Profile
    • 7.20.2 ImmuONE Main Business
    • 7.20.3 ImmuONE Microphysiological System Products, Services and Solutions
    • 7.20.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2019-2024)
    • 7.20.5 ImmuONE Recent Developments
  • 7.21 React4life
    • 7.21.1 React4life Profile
    • 7.21.2 React4life Main Business
    • 7.21.3 React4life Microphysiological System Products, Services and Solutions
    • 7.21.4 React4life Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.22 AlveoliX
    • 7.22.1 AlveoliX Profile
    • 7.22.2 AlveoliX Main Business
    • 7.22.3 AlveoliX Microphysiological System Products, Services and Solutions
    • 7.22.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.23 BiomimX
    • 7.23.1 BiomimX Profile
    • 7.23.2 BiomimX Main Business
    • 7.23.3 BiomimX Microphysiological System Products, Services and Solutions
    • 7.23.4 BiomimX Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.24 Aracari Bio
    • 7.24.1 Aracari Bio Profile
    • 7.24.2 Aracari Bio Main Business
    • 7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions
    • 7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.25 StemPharm
    • 7.25.1 StemPharm Profile
    • 7.25.2 StemPharm Main Business
    • 7.25.3 StemPharm Microphysiological System Products, Services and Solutions
    • 7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.26 SynVivo
    • 7.26.1 SynVivo Profile
    • 7.26.2 SynVivo Main Business
    • 7.26.3 SynVivo Microphysiological System Products, Services and Solutions
    • 7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2019-2024)

8 Industry Chain Analysis

  • 8.1 Microphysiological System Industrial Chain
  • 8.2 Microphysiological System Upstream Analysis
    • 8.2.1 Upstream Analysis
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Downstream Analysis (Customers Analysis)
  • 8.4 Sales Model and Sales Channels

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer